Literature DB >> 29133496

Factors Influencing Allopurinol Initiation in Primary Care.

Lorna E Clarson1, Samantha L Hider2,3, John Belcher2, Edward Roddy2,3, Christian D Mallen2.   

Abstract

Despite guidance on appropriate initiation, urate-lowering therapy is prescribed for only a minority of patients with gout. Electronic health records for 8,142 patients with gout were used to investigate the effect of age, sex, comorbidities, number of consultations, and meeting internationally agreed eligibility criteria on time to allopurinol initiation. Time to first prescription was modeled using multilevel Cox proportional hazards regression. Allopurinol initiation was positively associated with meeting eligibility criteria at diagnosis of gout, but negatively associated with becoming eligible after diagnosis. Managing gout as a chronic disease, with regular reviews to discuss allopurinol treatment, may reduce barriers to treatment.
© 2017 Annals of Family Medicine, Inc.

Entities:  

Keywords:  allopurinol; gout; primary care

Mesh:

Substances:

Year:  2017        PMID: 29133496      PMCID: PMC5683869          DOI: 10.1370/afm.2137

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  10 in total

1.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

Review 2.  Management of gout in general practice--a systematic review.

Authors:  Andrew Jeyaruban; Sarah Larkins; Muriel Soden
Journal:  Clin Rheumatol       Date:  2014-09-17       Impact factor: 2.980

3.  A qualitative study to explore health professionals' experience of treating gout: understanding perceived barriers to effective gout management.

Authors:  Chloe Humphrey; Richard Hulme; Nicola Dalbeth; Peter Gow; Bruce Arroll; Karen Lindsay
Journal:  J Prim Health Care       Date:  2016-06

Review 4.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

5.  Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.

Authors:  Edward Roddy; Weiya Zhang; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2007-05-15       Impact factor: 19.103

6.  Patient and provider barriers to effective management of gout in general practice: a qualitative study.

Authors:  Karen Spencer; Alison Carr; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2012-03-22       Impact factor: 19.103

7.  Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Christian Mallen; Weiya Zhang; Michael Doherty
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

8.  Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink.

Authors:  Lorna E Clarson; Samantha L Hider; John Belcher; Carl Heneghan; Edward Roddy; Christian D Mallen
Journal:  Ann Rheum Dis       Date:  2014-08-27       Impact factor: 19.103

9.  A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.

Authors:  Jane C Richardson; Jennifer Liddle; Christian D Mallen; Edward Roddy; Samantha Hider; Suman Prinjha; Sue Ziebland
Journal:  BMC Musculoskelet Disord       Date:  2016-06-06       Impact factor: 2.362

10.  A cross-sectional internet-based patient survey of the management strategies for gout.

Authors:  Jasvinder A Singh; Nipam Shah; N Lawrence Edwards
Journal:  BMC Complement Altern Med       Date:  2016-03-01       Impact factor: 3.659

  10 in total
  1 in total

1.  What factors contribute to uncontrolled gout and hospital admission? A qualitative study of inpatients and their primary care practitioners.

Authors:  Darren Chyi Hsiang Kong; Elizabeth Ann Sturgiss; Annamma Kochummen Dorai Raj; Kieran Fallon
Journal:  BMJ Open       Date:  2019-12-23       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.